Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC

Name: Adebrelimab Combined with Irinotecan Liposomes, 5-FU, CF ± Lenvatinib As First-line Treatment for Advanced ICC
License: Public Domain

Harbin Medical University

ClinicalTrials.gov · Datasets · License: Public Domain

intrahepatic cholangiocarcinoma (icc)

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 405235
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.